| |
G2 without a history of VTE (n = 5)
|
G2 with history of VTE (n = 3)
|
M1 without a history of VTE (n = 11)
|
M1 with history of VTE (n = 8)
|
All sarcoma patients without history of VTE (n = 28)
|
All sarcoma patients with history of VTE (n = 11)
|
Healthy controls (n = 17)
|
p-value of G2 patients with VTE vs controls
|
p-value of M1 patients with vs without VTE
|
p-value of all patients with VTE vs without VTE
|
|---|
|
Age (years)
|
69.4 ± 10.7
|
54.3 ± 3.9
|
56.8 ± 10.3
|
52.13 ± 14.4
|
58.1 ± 12.6
|
52.7 ± 12.4
|
48 ± 10.0
|
0.3179
|
0.4426
|
0.2460
|
|
BMI (kg/m2)
|
25.5 ± 2.5
|
23.3 ± 3.2
|
24.4 ± 4.2
|
24.3 ± 4.8
|
24.7 ± 3.6
|
24.1 ± 4.4
|
24.2 ± 3.4
|
0.7287
|
0.9756
|
0.6577
|
|
Hb (g/dl)
|
13.5 ± 0.9
|
10.5 ± 2.7
|
11.6 ± 1.6
|
12.7 ± 1.8
|
12.8 ± 1.8
|
12 ± 2.4
|
14,63 ± 1.0
|
0.0003
|
0.2561
|
0.3167
|
|
Platelets (th/μl)
|
256.0 ± 16.5
|
401.0 ± 150.1
|
254.0 ± 123.3
|
354.9 ± 144.4
|
261.8 ± 98.3
|
368.7 ± 147.7
|
227.3 ± 45.5
|
0.0018
|
0.1554
|
0.0186
|
|
Leukocytes (th/μl)
|
6.3 ± 1.0
|
9.5 ± 3.3
|
7.8 ± 6.5
|
7.9 ± 3.6
|
7.3 ± 4.3
|
8.4 ± 3.6
|
5.8 ± 1.2
|
0.0032
|
0.9773
|
0.4848
|
- Data are presented as mean value ± standard deviation (SD). p-values were determined using Student’s t-tests for independent samples. p-values <0.05 are marked in bold
